PPA
NGNE icon

Parametric Portfolio Associates’s Neurogene NGNE Stock Holding History

Parametric Portfolio Associates’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$220K Buy
5,839
+391
+7% +$22.8K ﹤0.01% 3407
2021
Q4 		$525K Buy
+5,448
New +$664K ﹤0.01% 3054

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Parametric Portfolio Associates's NGNE Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Neurogene (NGNE) stake by 7.2% in Q1 2022, buying an estimated $22.8K and bringing the position to 5,839 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #3407.

Parametric Portfolio Associates first reported a position in NGNE in Q4 2021 and has held it in 2 quarters since. The position peaked at $525K in Q4 2021. 81 funds tracked by Wall St. Rank hold NGNE as of Q1 2022.

  • Parametric Portfolio Associates held 5,839 shares of Neurogene worth $220K as of Q1 2022.
  • Parametric Portfolio Associates bought 391 Neurogene shares in Q1 2022, an estimated $22.8K.
  • Neurogene made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3407 holding.
  • Parametric Portfolio Associates first reported a position in Neurogene in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Neurogene position peaked at $525K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Neurogene as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.